Inhibiting the colony-stimulating factor 1 receptor (CSF1R) can repolarize macrophages towards a pro-inflammatory M1-like phenotype, enhancing anti-tumor immunity and counteracting the tumor-supportive effects of the SASP. The gene discussed is CSF1R; the disease is neoplasm.